Introduction. Part 1. ASTROCYTOMAS. DIAGNOSIS AND BIOMARKERS
1. Methylation in malignant astrocytomas
2. Deciphering the function of doppel protein in astrocytomas
3. Astrocytic tumors: role of antiapoptotic proteins
4. Astrocytomas: role of wnt/β- catenin/tcf signaling pathway
5. Subependymal giant cell astrocytoma: role of mtor pathway
6. Role of progesterone preceptor isoforms in human astrocytomas growth
7. Astrocytic tumors: role of carbonic anhydrase ix
8. Development of cysts in pilocytic astrocytomas: role of eosinophilic granular bodies (method)
9. Role of synemin in astrocytoma cell migration
10. Diffuse astrocytomas: immunohistochemistry of mgmt expression.-11. Central nervous system germ cell tumors: an epidemiology review
12. Raf genes and mapk activation in pilocytic astrocytomas
13. Biomarker discovery in central nervous system neoplasms: past, present and future
14. Astrocytomas: role of taurine in apoptosis using magnetic resonance spectroscopy
15. Imaging of hypoxia-inducible factor-1-active regions in tumors using a pos and 123i-ibb method
16. Diffuse low-grade astrocytomas: p53-mediated inhibition of angiogenesis
17. Spontaneous regression of cerebellar astrocytomas mansoor foroughi, shibu pillai, and paul steenbok
18. Subependymal giant cell astrocytoma: gene expression profiling magdalena ewa tyburczy and bozena kaminska. THERAPY. - 19. Time- resolved laser induced fluorescence spectroscopy (trlifs): a tool for intra-operative diagnosis of brain tumors and maximizing extent of surgical resection
20. Magnetic resonance-guided laser interstitial thermal therapy for brain tumors
21. Nanotechnology-based therapy for malignant tumors of the central nervous system
22. Pilocytic astrocytoma: pthological and immunohistochemical factors affecting surgical treatment and surveillance
23. Pilomyxoid astrocytoma: chemotherapy hitoshi tsugu, shinya oshiro, fuminari komatsu, hiroshi abe, takeo fukushima, tooru inoue, fumio yanai, yuko nomura. PROGNOSIS
24. Astrocytomas: predicting survival and recurrence using cerebral blood volume measurements.-25. Electronic patient-reported outcome monitoring (eprom) in brain tumour patients. Part 2. HEMANGIOBLASTOMA
26. Intra-operative icg use in the management of hemangioblastomas
27. Hemangioblastoma cysts: diagnosis using fluorescence with 5-aminolevulinic acid
28. Hemangioblastoma-stereotactic radiosurgery anand veeravagu, bowen jiang, and steven chang. Part 3.GANGLIOGLIOMA
29. Gangliogliomas: molecular pathogenesis and epileptogenesis eleonora aronica and pitt niehusmann
30. Epilepsy-associated gangliogliomas: identification of genes with altered expression. Index.